A critical appraisal of the use of recombinant factor VIIa in acquired bleeding conditions

British Journal of Haematology

Volumn 133, Issue 4, 2006, Pages 355-363

  Mittal, Sajjan ^a   Watson, Henry G ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Bleeding disorder; Clinical studies; Haemorrhage; Haemostasis; Recombinant factor VIIa

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A INHIBITOR; BLOOD CLOTTING FACTOR 8 INHIBITOR; BLOOD CLOTTING FACTOR 9 INHIBITOR; BLOOD CLOTTING INHIBITOR; COUMARIN; HEMOSTATIC AGENT; HEPARIN; IDRAPARINUX; LEPIRUDIN; MELAGATRAN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN; THROMBIN INHIBITOR; UNCLASSIFIED DRUG; VITAMIN K GROUP;

AMINO ACID SEQUENCE; ANION EXCHANGE CHROMATOGRAPHY; BLEEDING DISORDER; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HEMOPHILIA; HEMOSTASIS; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; PH; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; TEMPERATURE; THROMBOCYTE; THROMBOEMBOLISM;

BLOOD COAGULATION DISORDERS; COAGULANTS; FACTOR VIIA; HEMORRHAGE; HEMOSTASIS; HEMOSTASIS, SURGICAL; HUMANS; RECOMBINANT PROTEINS;

EID: 33645815503     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06023.x     Document Type: Review

References (53)

1. Allen G.A. Wolberg A.S. Oliver J.A. Hoffman M. Roberts H.R. Monroe D.M. 2004 Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system Journal of Thrombosis and Haemostasis 2 402 413
2. Arkin S. Blei F. Fetten J. Foulke R. Gilchrist G.S. Heisel M.A. Key N. Kisker C.T. Kitchen C. Shafer F.E. Shah P.C. Strickland D. 2000 Human coagulation factor FVIIa (recombinant) in the management of limb-threatening bleeds unresponsive to alternative therapies: results from the NovoSeven emergency-use programme in patients with severe haemophilia or with acquired inhibitors Blood Coagulation and Fibrinolysis 11 255 259
3. Bijsterveld N.R. Moons A.H. Boekholdt S.M. van Aken B.E. Fennema H. Peters R.J. Meijers J.C. Buller H.R. Levi M. 2002 Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers Circulation 106 2550 2554
4. Bjoern S. Foster D.C. Thim L. Wiberg F.C. Christensen M. Komiyama Y. Pedersen A.H. Kisiel W. 1991 Human plasma and recombinant factor VII. Characterization of O-glycosylations at serine residues 52 and 60 and effects of site-directed mutagenesis of serine 52 to alanine Journal of Biological Chemistry 266 11051 11057
5. Bjorquist P. Bostrom S. 1997 Determination of the kinetic constants of tissue factor/factor VII/factor VIIA and antithrombin/heparin using surface plasmon resonance Thrombosis Research 85 225 236
6. Boffard K.D. Riou B. Warren B. Choong P.I. Rizoli S. Rossaint R. Axelsen M. Kluger Y. 2005 Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials Journal of Trauma 59 8 15
7. Bom V.J. Bertina R.M. 1990 The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII Biochemical Journal 265 327 336
8. Bosch J. Thabut D. Bendtsen F. D'Amico G. Albillos A. Gonzalez A.J. Fabricius S. Erhardtsen E. de Franchis R. 2004 Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial Gastroenterology 127 1123 1130
9. British Committee for Standards in Haematology Blood Transfusion Task Force 1988 Guidelines for transfusion for massive blood loss. A publication of the British Society for Haematology. British Committee for Standards in Haematology Blood Transfusion Task Force Clinical and Laboratory Haematology 10 265 273
10. Butenas S. Brummel K.E. Bouchard B.A. Mann K.G. 2003 How factor VIIa works in hemophilia Journal of Thrombosis and Haemostasis 1 1158 1160
11. ten Cate H. Bauer K.A. Levi M. Edgington T.S. Sublett R.D. Barzegar S. Kass B.L. Rosenberg R.D. 1993 The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor Journal of Clinical Investigation 92 1207 1212
12. Clark A.D. Gordon W.C. Walker I.D. Tait R.C. 2004 'Last-ditch' use of recombinant factor VIIa in patients with massive haemorrhage is ineffective Vox Sanguinis 86 120 124
13. Deveras R.A. Kessler C.M. 2002 Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate Annals of Internal Medicine 137 884 888
14. Dutton R.P. McCunn M. Hyder M. D'Angelo M. O'Connor J. Hess J.R. Scalea T.M. 2004 Factor VIIa for correction of traumatic coagulopathy Journal of Trauma 57 709 718
15. Erhardtsen E. 2000 Pharmacokinetics of recombinant activated factor VII (rFVIIa) Seminars in Thrombosis and Hemostasis 26 385 391
16. Erhardtsen E. Nony P. Dechavanne M. Ffrench P. Boissel J.P. Hedner U. 1998 The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0 Blood Coagulation and Fibrinolysis 9 741 748
17. Friederich P.W. Henny C.P. Messelink E.J. Geerdink M.G. Keller T. Kurth K.H. Buller H.R. Levi M. 2003 Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial The Lancet 361 201 205
18. Gofrit O.N. Leibovici D. Shapira S.C. Shemer J. Stein M. Michaelson M. 1997 The trimodal death distribution of trauma victims: military experience from the Lebanon War Military Medicine 162 24 26
19. Hay C.R. Negrier C. Ludlam C.A. 1997 The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study Thrombosis and Haemostasis 78 1463 1467
20. Hedner U. 1990 Factor VIIa in the treatment of haemophilia Blood Coagulation and Fibrinolysis 1 307 317
21. Hedner U. Erhardtsen E. 2002 Potential role for rFVIIa in transfusion medicine Transfusion 42 114 124
22. Hendriks H.G. Meijer K. de Wolf J.T. Klompmaker I.J. Porte R.J. de Kam P.J. Hagenaars A.J. Melsen T. Slooff M.J. van der Meer J. 2001 Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study Transplantation 71 402 405
23. Hoffman M. Monroe D.M. Roberts H.R. 1994 Human monocytes support factor X activation by factor VIIa, independent of tissue factor: implications for the therapeutic mechanism of high-dose factor VIIa in hemophilia Blood 83 38 42
24. Ingerslev J. 2000 Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors Seminars in Thrombosis and Hemostasis 26 425 432
25. Kenet G. Walden R. Eldad A. Martinowitz U. 1999 Treatment of traumatic bleeding with recombinant factor VIIa The Lancet 354 1879
26. Kjalke M. Ezban M. Monroe D.M. Hoffman M. Roberts H.R. Hedner U. 2001 High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system British Journal of Haematology 114 114 120
27. Lindley C.M. Sawyer W.T. Macik B.G. Lusher J. Harrison J.F. Baird-Cox K. Birch K. Glazer S. Roberts H.R. 1994 Pharmacokinetics and pharmacodynamics of recombinant factor VIIa Clinical Pharmacology and Therapeutics 55 638 648
28. Lisman T. Bijsterveld N.R. Adelmeijer J. Meijers J.C. Levi M. Nieuwenhuis H.K. De Groot P.G. 2003 Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux Journal of Thrombosis and Haemostasis 1 2368 2373
29. Lisman T. Adelmeijer J. Cauwenberghs S. Van Pampus E.C. Heemskerk J.W. De Groot P.G. 2005 Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count Journal of Thrombosis and Haemostasis 3 742 751
30. Lodge J.P. Jonas S. Oussoultzoglou E. Malago M. Jayr C. Cherqui D. Anthuber M. Mirza D.F. Kuhlman L. Bechstein W.O. Diaz J.C. Tartiere J. Eyraud D. Fridberg M. Erhardtsen E. Mimoz O. 2005a Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial Anesthesiology 102 269 275
31. Lodge J.P. Jonas S. Jones R.M. Olausson M. Mir-Pallardo J. Soefelt S. Garcia-Valdecasas J.C. McAlister V. Mirza D.F. 2005b Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation Liver Transplantation 11 973 979
32. Lusher J.M. Roberts H.R. Davignon G. Joist J.H. Smith H. Shapiro A. Laurian Y. Kasper C.K. Mannucci P.M. 1998 A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group Haemophilia 4 790 798
33. MacLaren R. Weber L.A. Brake H. Gardner M.A. Tanzi M. 2005 A multicenter assessment of recombinant factor VIIa off-label usage: clinical experiences and associated outcomes Transfusion 45 1434 1442
34. Martinowitz U. Michaelson M. 2005 Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force Journal of Thrombosis and Haemostasis 3 640 648
35. Martinowitz U. Kenet G. Segal E. Luboshitz J. Lubetsky A. Ingerslev J. Lynn M. 2001 Recombinant activated factor VII for adjunctive hemorrhage control in trauma Journal of Trauma 51 431 438
36. Mayer S.A. Brun N.C. Begtrup K. Broderick J. Davis S. Diringer M.N. Skolnick B.E. Steiner T. 2005 Recombinant activated factor VII for acute intracerebral hemorrhage New England Journal of Medicine 352 777 785
37. Meng Z.H. Wolberg A.S. Monroe D.M. III. Hoffman M. 2003 The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients Journal of Trauma 55 886 891
38. Monroe D.M. Hoffman M. Oliver J.A. Roberts H.R. 1997 Platelet activity of high-dose factor VIIa is independent of tissue factor British Journal of Haematology 99 542 547
39. Mor E. Jennings L. Gonwa T.A. Holman M.J. Gibbs J. Solomon H. Goldstein R.M. Husberg B.S. Watemberg I.A. Klintmalm G.B. 1993 The impact of operative bleeding on outcome in transplantation of the liver Surgery, Gynecology and Obstetrics 176 219 227
40. O'Connell N.M. Perry D.J. Hodgson A.J. O'Shaughnessy D.F. Laffan M.A. Smith O.P. 2003 Recombinant FVIIa in the management of uncontrolled hemorrhage Transfusion 43 1711 1716
41. O'Shaughnessy D.F. Atterbury C. Bolton M.P. Murphy M. Thomas D. Yates S. Williamson L.M. 2004 Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant British Journal of Haematology 126 11 28
42. Pihusch M. Bacigalupo A. Szer J. von Depka P.M. Gaspar-Blaudschun B. Hyveled L. Brenner B. 2005 Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation Journal of Thrombosis and Haemostasis 3 1935 1944
43. Planinsic R.M. van der Meer J. Testa G. Grande L. Candela A. Porte R.J. Ghobrial R.M. Isoniemi H. Schelde P.B. Erhardtsen E. Klintmalm G. Emre S. 2005 Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease Liver Transplantation 11 895 900
44. Porte R.J. Knot E.A. Bontempo F.A. 1989 Hemostasis in liver transplantation Gastroenterology 97 488 501
45. Rao L.V. Rapaport S.I. 1990 Factor VIIa-catalyzed activation of factor X independent of tissue factor: its possible significance for control of hemophilic bleeding by infused factor VIIa Blood 75 1069 1073
46. Sauaia A. Moore F.A. Moore E.E. Moser K.S. Brennan R. Read R.A. Pons P.T. 1995 Epidemiology of trauma deaths: a reassessment Journal of Trauma 38 185 193
47. Scharrer I. 1999 Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency Haemophilia 5 253 259
48. Sorensen B. Johansen P. Nielsen G.L. Sorensen J.C. Ingerslev J. 2003 Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects Blood Coagulation and Fibrinolysis 14 469 477
49. Thim L. Bjoern S. Christensen M. Nicolaisen E.M. Lund-Hansen T. Pedersen A.H. Hedner U. 1988 Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cells Biochemistry 27 7785 7793
50. Vlot A.J. Ton E. Mackaay A.J. Kramer M.H. Gaillard C.A. 2000 Treatment of a severely bleeding patient without preexisting coagulopathy with activated recombinant factor VII American Journal of Medicine 108 421 423
51. Watson H.G. Chee Y.L. Greaves M. 2001 Rare acquired bleeding disorders Reviews in Clinical and Experimental Hematology 5 405 429
52. Wolberg A.S. Monroe D.M. Roberts H.R. Hoffman M. 2003 Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk Blood 101 3008 3013
53. Wolzt M. Levi M. Sarich T.C. Bostrom S.L. Eriksson U.G. Eriksson-Lepkowska M. Svensson M. Weitz J.I. Elg M. Wahlander K. 2004 Effect of recombinant factor VIIa on melagatran-induced inhibition of thrombin generation and platelet activation in healthy volunteers Thrombosis and Haemostasis 91 1090 1096